nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Cholestasis—Niacin—atherosclerosis	0.0197	0.0199	CcSEcCtD
Ceftibuten—Vaginal inflammation—Niacin—atherosclerosis	0.015	0.0151	CcSEcCtD
Ceftibuten—Eructation—Niacin—atherosclerosis	0.0147	0.0148	CcSEcCtD
Ceftibuten—Vaginal infection—Niacin—atherosclerosis	0.0141	0.0143	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Lovastatin—atherosclerosis	0.014	0.0141	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Simvastatin—atherosclerosis	0.0131	0.0132	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Pravastatin—atherosclerosis	0.0119	0.012	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.0114	0.0115	CcSEcCtD
Ceftibuten—Jaundice—Rosuvastatin—atherosclerosis	0.0112	0.0113	CcSEcCtD
Ceftibuten—Haematuria—Rosuvastatin—atherosclerosis	0.011	0.0111	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.0107	0.0108	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00967	0.00975	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00964	0.00972	CcSEcCtD
Ceftibuten—Jaundice—Ezetimibe—atherosclerosis	0.00933	0.0094	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00905	0.00912	CcSEcCtD
Ceftibuten—Jaundice—Simvastatin—atherosclerosis	0.0089	0.00897	CcSEcCtD
Ceftibuten—Flatulence—Rosuvastatin—atherosclerosis	0.00887	0.00894	CcSEcCtD
Ceftibuten—Dysuria—Pravastatin—atherosclerosis	0.00865	0.00872	CcSEcCtD
Ceftibuten—Erythema multiforme—Lovastatin—atherosclerosis	0.00828	0.00835	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00818	0.00825	CcSEcCtD
Ceftibuten—Jaundice—Niacin—atherosclerosis	0.00817	0.00823	CcSEcCtD
Ceftibuten—Erythema multiforme—Ezetimibe—atherosclerosis	0.00812	0.00819	CcSEcCtD
Ceftibuten—Jaundice—Pravastatin—atherosclerosis	0.00804	0.00811	CcSEcCtD
Ceftibuten—Chills—Lovastatin—atherosclerosis	0.00786	0.00792	CcSEcCtD
Ceftibuten—Erythema multiforme—Simvastatin—atherosclerosis	0.00775	0.00781	CcSEcCtD
Ceftibuten—Haemoglobin—Niacin—atherosclerosis	0.00756	0.00762	CcSEcCtD
Ceftibuten—Haemorrhage—Niacin—atherosclerosis	0.00752	0.00758	CcSEcCtD
Ceftibuten—Flatulence—Lovastatin—atherosclerosis	0.00751	0.00757	CcSEcCtD
Ceftibuten—Dysgeusia—Lovastatin—atherosclerosis	0.00747	0.00753	CcSEcCtD
Ceftibuten—Flatulence—Ezetimibe—atherosclerosis	0.00737	0.00743	CcSEcCtD
Ceftibuten—Chills—Simvastatin—atherosclerosis	0.00735	0.00741	CcSEcCtD
Ceftibuten—Flatulence—Simvastatin—atherosclerosis	0.00703	0.00709	CcSEcCtD
Ceftibuten—Erythema multiforme—Pravastatin—atherosclerosis	0.007	0.00706	CcSEcCtD
Ceftibuten—Dysgeusia—Simvastatin—atherosclerosis	0.00699	0.00704	CcSEcCtD
Ceftibuten—Chills—Niacin—atherosclerosis	0.00675	0.00681	CcSEcCtD
Ceftibuten—Chills—Pravastatin—atherosclerosis	0.00665	0.0067	CcSEcCtD
Ceftibuten—Insomnia—Rosuvastatin—atherosclerosis	0.00664	0.0067	CcSEcCtD
Ceftibuten—Paraesthesia—Rosuvastatin—atherosclerosis	0.00659	0.00665	CcSEcCtD
Ceftibuten—Dyspepsia—Rosuvastatin—atherosclerosis	0.00646	0.00652	CcSEcCtD
Ceftibuten—Flatulence—Niacin—atherosclerosis	0.00645	0.00651	CcSEcCtD
Ceftibuten—Flatulence—Pravastatin—atherosclerosis	0.00635	0.00641	CcSEcCtD
Ceftibuten—Dry mouth—Lovastatin—atherosclerosis	0.00635	0.0064	CcSEcCtD
Ceftibuten—Dysgeusia—Pravastatin—atherosclerosis	0.00632	0.00637	CcSEcCtD
Ceftibuten—Constipation—Rosuvastatin—atherosclerosis	0.00628	0.00633	CcSEcCtD
Ceftibuten—Dry mouth—Ezetimibe—atherosclerosis	0.00623	0.00628	CcSEcCtD
Ceftibuten—Anaphylactic shock—Lovastatin—atherosclerosis	0.00622	0.00627	CcSEcCtD
Ceftibuten—Anaphylactic shock—Ezetimibe—atherosclerosis	0.0061	0.00615	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00601	0.00605	CcSEcCtD
Ceftibuten—Anorexia—Lovastatin—atherosclerosis	0.00593	0.00598	CcSEcCtD
Ceftibuten—Urticaria—Rosuvastatin—atherosclerosis	0.00583	0.00588	CcSEcCtD
Ceftibuten—Anaphylactic shock—Simvastatin—atherosclerosis	0.00582	0.00587	CcSEcCtD
Ceftibuten—Abdominal pain—Rosuvastatin—atherosclerosis	0.00581	0.00585	CcSEcCtD
Ceftibuten—Insomnia—Lovastatin—atherosclerosis	0.00563	0.00567	CcSEcCtD
Ceftibuten—Paraesthesia—Lovastatin—atherosclerosis	0.00559	0.00563	CcSEcCtD
Ceftibuten—Anorexia—Simvastatin—atherosclerosis	0.00555	0.00559	CcSEcCtD
Ceftibuten—Dyspnoea—Lovastatin—atherosclerosis	0.00555	0.00559	CcSEcCtD
Ceftibuten—Insomnia—Ezetimibe—atherosclerosis	0.00552	0.00557	CcSEcCtD
Ceftibuten—Paraesthesia—Ezetimibe—atherosclerosis	0.00548	0.00553	CcSEcCtD
Ceftibuten—Dyspepsia—Lovastatin—atherosclerosis	0.00548	0.00552	CcSEcCtD
Ceftibuten—Dry mouth—Niacin—atherosclerosis	0.00545	0.0055	CcSEcCtD
Ceftibuten—Dyspnoea—Ezetimibe—atherosclerosis	0.00544	0.00549	CcSEcCtD
Ceftibuten—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00541	0.00545	CcSEcCtD
Ceftibuten—Decreased appetite—Lovastatin—atherosclerosis	0.00541	0.00545	CcSEcCtD
Ceftibuten—Dyspepsia—Ezetimibe—atherosclerosis	0.00537	0.00542	CcSEcCtD
Ceftibuten—Cefdinir—MPO—atherosclerosis	0.00537	0.674	CrCbGaD
Ceftibuten—Fatigue—Lovastatin—atherosclerosis	0.00537	0.00541	CcSEcCtD
Ceftibuten—Anaphylactic shock—Niacin—atherosclerosis	0.00535	0.00539	CcSEcCtD
Ceftibuten—Constipation—Lovastatin—atherosclerosis	0.00532	0.00536	CcSEcCtD
Ceftibuten—Decreased appetite—Ezetimibe—atherosclerosis	0.00531	0.00535	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00527	0.00531	CcSEcCtD
Ceftibuten—Asthenia—Rosuvastatin—atherosclerosis	0.00527	0.00531	CcSEcCtD
Ceftibuten—Insomnia—Simvastatin—atherosclerosis	0.00527	0.00531	CcSEcCtD
Ceftibuten—Anaphylactic shock—Pravastatin—atherosclerosis	0.00526	0.00531	CcSEcCtD
Ceftibuten—Fatigue—Ezetimibe—atherosclerosis	0.00526	0.00531	CcSEcCtD
Ceftibuten—Paraesthesia—Simvastatin—atherosclerosis	0.00523	0.00527	CcSEcCtD
Ceftibuten—Constipation—Ezetimibe—atherosclerosis	0.00522	0.00526	CcSEcCtD
Ceftibuten—Pruritus—Rosuvastatin—atherosclerosis	0.0052	0.00524	CcSEcCtD
Ceftibuten—Dyspnoea—Simvastatin—atherosclerosis	0.00519	0.00523	CcSEcCtD
Ceftibuten—Dyspepsia—Simvastatin—atherosclerosis	0.00512	0.00517	CcSEcCtD
Ceftibuten—Anorexia—Niacin—atherosclerosis	0.0051	0.00514	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00509	0.00513	CcSEcCtD
Ceftibuten—Decreased appetite—Simvastatin—atherosclerosis	0.00506	0.0051	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00503	0.00507	CcSEcCtD
Ceftibuten—Diarrhoea—Rosuvastatin—atherosclerosis	0.00502	0.00507	CcSEcCtD
Ceftibuten—Fatigue—Simvastatin—atherosclerosis	0.00502	0.00506	CcSEcCtD
Ceftibuten—Anorexia—Pravastatin—atherosclerosis	0.00502	0.00506	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00499	0.00503	CcSEcCtD
Ceftibuten—Constipation—Simvastatin—atherosclerosis	0.00498	0.00502	CcSEcCtD
Ceftibuten—Urticaria—Lovastatin—atherosclerosis	0.00494	0.00498	CcSEcCtD
Ceftibuten—Body temperature increased—Lovastatin—atherosclerosis	0.00492	0.00496	CcSEcCtD
Ceftibuten—Abdominal pain—Lovastatin—atherosclerosis	0.00492	0.00496	CcSEcCtD
Ceftibuten—Dizziness—Rosuvastatin—atherosclerosis	0.00486	0.0049	CcSEcCtD
Ceftibuten—Urticaria—Ezetimibe—atherosclerosis	0.00485	0.00489	CcSEcCtD
Ceftibuten—Insomnia—Niacin—atherosclerosis	0.00483	0.00487	CcSEcCtD
Ceftibuten—Abdominal pain—Ezetimibe—atherosclerosis	0.00483	0.00486	CcSEcCtD
Ceftibuten—Body temperature increased—Ezetimibe—atherosclerosis	0.00483	0.00486	CcSEcCtD
Ceftibuten—Paraesthesia—Niacin—atherosclerosis	0.0048	0.00484	CcSEcCtD
Ceftibuten—Dyspnoea—Niacin—atherosclerosis	0.00477	0.0048	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00476	0.0048	CcSEcCtD
Ceftibuten—Insomnia—Pravastatin—atherosclerosis	0.00476	0.0048	CcSEcCtD
Ceftibuten—Somnolence—Niacin—atherosclerosis	0.00475	0.00479	CcSEcCtD
Ceftibuten—Paraesthesia—Pravastatin—atherosclerosis	0.00473	0.00476	CcSEcCtD
Ceftibuten—Dyspepsia—Niacin—atherosclerosis	0.00471	0.00474	CcSEcCtD
Ceftibuten—Dyspnoea—Pravastatin—atherosclerosis	0.00469	0.00473	CcSEcCtD
Ceftibuten—Decreased appetite—Niacin—atherosclerosis	0.00465	0.00468	CcSEcCtD
Ceftibuten—Dyspepsia—Pravastatin—atherosclerosis	0.00463	0.00467	CcSEcCtD
Ceftibuten—Rash—Rosuvastatin—atherosclerosis	0.00463	0.00467	CcSEcCtD
Ceftibuten—Dermatitis—Rosuvastatin—atherosclerosis	0.00463	0.00466	CcSEcCtD
Ceftibuten—Urticaria—Simvastatin—atherosclerosis	0.00462	0.00466	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Niacin—atherosclerosis	0.00461	0.00465	CcSEcCtD
Ceftibuten—Body temperature increased—Simvastatin—atherosclerosis	0.0046	0.00464	CcSEcCtD
Ceftibuten—Abdominal pain—Simvastatin—atherosclerosis	0.0046	0.00464	CcSEcCtD
Ceftibuten—Headache—Rosuvastatin—atherosclerosis	0.0046	0.00464	CcSEcCtD
Ceftibuten—Hypersensitivity—Lovastatin—atherosclerosis	0.00459	0.00462	CcSEcCtD
Ceftibuten—Decreased appetite—Pravastatin—atherosclerosis	0.00458	0.00461	CcSEcCtD
Ceftibuten—Fatigue—Pravastatin—atherosclerosis	0.00454	0.00457	CcSEcCtD
Ceftibuten—Constipation—Pravastatin—atherosclerosis	0.0045	0.00454	CcSEcCtD
Ceftibuten—Hypersensitivity—Ezetimibe—atherosclerosis	0.0045	0.00453	CcSEcCtD
Ceftibuten—Asthenia—Lovastatin—atherosclerosis	0.00447	0.0045	CcSEcCtD
Ceftibuten—Pruritus—Lovastatin—atherosclerosis	0.0044	0.00444	CcSEcCtD
Ceftibuten—Asthenia—Ezetimibe—atherosclerosis	0.00438	0.00441	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Niacin—atherosclerosis	0.00437	0.00441	CcSEcCtD
Ceftibuten—Nausea—Rosuvastatin—atherosclerosis	0.00436	0.0044	CcSEcCtD
Ceftibuten—Pruritus—Ezetimibe—atherosclerosis	0.00432	0.00435	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Pravastatin—atherosclerosis	0.0043	0.00434	CcSEcCtD
Ceftibuten—Hypersensitivity—Simvastatin—atherosclerosis	0.00429	0.00432	CcSEcCtD
Ceftibuten—Diarrhoea—Lovastatin—atherosclerosis	0.00426	0.00429	CcSEcCtD
Ceftibuten—Urticaria—Niacin—atherosclerosis	0.00425	0.00428	CcSEcCtD
Ceftibuten—Body temperature increased—Niacin—atherosclerosis	0.00423	0.00426	CcSEcCtD
Ceftibuten—Abdominal pain—Niacin—atherosclerosis	0.00423	0.00426	CcSEcCtD
Ceftibuten—Urticaria—Pravastatin—atherosclerosis	0.00418	0.00421	CcSEcCtD
Ceftibuten—Asthenia—Simvastatin—atherosclerosis	0.00418	0.00421	CcSEcCtD
Ceftibuten—Diarrhoea—Ezetimibe—atherosclerosis	0.00418	0.00421	CcSEcCtD
Ceftibuten—Abdominal pain—Pravastatin—atherosclerosis	0.00416	0.00419	CcSEcCtD
Ceftibuten—Body temperature increased—Pravastatin—atherosclerosis	0.00416	0.00419	CcSEcCtD
Ceftibuten—Pruritus—Simvastatin—atherosclerosis	0.00412	0.00415	CcSEcCtD
Ceftibuten—Dizziness—Lovastatin—atherosclerosis	0.00412	0.00415	CcSEcCtD
Ceftibuten—Dizziness—Ezetimibe—atherosclerosis	0.00404	0.00407	CcSEcCtD
Ceftibuten—Diarrhoea—Simvastatin—atherosclerosis	0.00398	0.00402	CcSEcCtD
Ceftibuten—Vomiting—Lovastatin—atherosclerosis	0.00396	0.00399	CcSEcCtD
Ceftibuten—Hypersensitivity—Niacin—atherosclerosis	0.00394	0.00397	CcSEcCtD
Ceftibuten—Rash—Lovastatin—atherosclerosis	0.00392	0.00396	CcSEcCtD
Ceftibuten—Dermatitis—Lovastatin—atherosclerosis	0.00392	0.00395	CcSEcCtD
Ceftibuten—Headache—Lovastatin—atherosclerosis	0.0039	0.00393	CcSEcCtD
Ceftibuten—Vomiting—Ezetimibe—atherosclerosis	0.00388	0.00391	CcSEcCtD
Ceftibuten—Hypersensitivity—Pravastatin—atherosclerosis	0.00388	0.00391	CcSEcCtD
Ceftibuten—Dizziness—Simvastatin—atherosclerosis	0.00385	0.00388	CcSEcCtD
Ceftibuten—Rash—Ezetimibe—atherosclerosis	0.00385	0.00388	CcSEcCtD
Ceftibuten—Dermatitis—Ezetimibe—atherosclerosis	0.00385	0.00388	CcSEcCtD
Ceftibuten—Asthenia—Niacin—atherosclerosis	0.00384	0.00387	CcSEcCtD
Ceftibuten—Headache—Ezetimibe—atherosclerosis	0.00382	0.00385	CcSEcCtD
Ceftibuten—Pruritus—Niacin—atherosclerosis	0.00378	0.00381	CcSEcCtD
Ceftibuten—Asthenia—Pravastatin—atherosclerosis	0.00378	0.00381	CcSEcCtD
Ceftibuten—Pruritus—Pravastatin—atherosclerosis	0.00372	0.00375	CcSEcCtD
Ceftibuten—Vomiting—Simvastatin—atherosclerosis	0.0037	0.00373	CcSEcCtD
Ceftibuten—Nausea—Lovastatin—atherosclerosis	0.0037	0.00373	CcSEcCtD
Ceftibuten—Rash—Simvastatin—atherosclerosis	0.00367	0.0037	CcSEcCtD
Ceftibuten—Dermatitis—Simvastatin—atherosclerosis	0.00367	0.0037	CcSEcCtD
Ceftibuten—Diarrhoea—Niacin—atherosclerosis	0.00366	0.00369	CcSEcCtD
Ceftibuten—Headache—Simvastatin—atherosclerosis	0.00365	0.00368	CcSEcCtD
Ceftibuten—Nausea—Ezetimibe—atherosclerosis	0.00363	0.00366	CcSEcCtD
Ceftibuten—Diarrhoea—Pravastatin—atherosclerosis	0.0036	0.00363	CcSEcCtD
Ceftibuten—Dizziness—Niacin—atherosclerosis	0.00353	0.00356	CcSEcCtD
Ceftibuten—Dizziness—Pravastatin—atherosclerosis	0.00348	0.00351	CcSEcCtD
Ceftibuten—Nausea—Simvastatin—atherosclerosis	0.00346	0.00349	CcSEcCtD
Ceftibuten—Vomiting—Niacin—atherosclerosis	0.0034	0.00343	CcSEcCtD
Ceftibuten—Rash—Niacin—atherosclerosis	0.00337	0.0034	CcSEcCtD
Ceftibuten—Dermatitis—Niacin—atherosclerosis	0.00337	0.00339	CcSEcCtD
Ceftibuten—Headache—Niacin—atherosclerosis	0.00335	0.00338	CcSEcCtD
Ceftibuten—Vomiting—Pravastatin—atherosclerosis	0.00335	0.00337	CcSEcCtD
Ceftibuten—Rash—Pravastatin—atherosclerosis	0.00332	0.00335	CcSEcCtD
Ceftibuten—Dermatitis—Pravastatin—atherosclerosis	0.00332	0.00334	CcSEcCtD
Ceftibuten—Headache—Pravastatin—atherosclerosis	0.0033	0.00332	CcSEcCtD
Ceftibuten—Nausea—Niacin—atherosclerosis	0.00318	0.0032	CcSEcCtD
Ceftibuten—Nausea—Pravastatin—atherosclerosis	0.00313	0.00315	CcSEcCtD
Ceftibuten—Ceftriaxone—ALB—atherosclerosis	0.00138	0.174	CrCbGaD
Ceftibuten—Cefalotin—ALB—atherosclerosis	0.00121	0.152	CrCbGaD
